Login / Signup

Loss-of-function mutation in PRMT9 causes abnormal synapse development by dysregulation of RNA alternative splicing.

Lei ShenXiaokuang MaYuanyuan WangZhihao WangYi ZhangHoang Quoc Hai PhamXiaoqun TaoYuehua CuiJing WeiDimitri LinTharindumala AbeywanadaSwanand HardikarLevon HalabelianNoah SmithJiameng DanDalia Barsyte-LovejoyShenfeng QiuYi XingYanzhong Yang
Published in: Nature communications (2024)
Protein arginine methyltransferase 9 (PRMT9) is a recently identified member of the PRMT family, yet its biological function remains largely unknown. Here, by characterizing an intellectual disability associated PRMT9 mutation (G189R) and establishing a Prmt9 conditional knockout (cKO) mouse model, we uncover an important function of PRMT9 in neuronal development. The G189R mutation abolishes PRMT9 methyltransferase activity and reduces its protein stability. Knockout of Prmt9 in hippocampal neurons causes alternative splicing of ~1900 genes, which likely accounts for the aberrant synapse development and impaired learning and memory in the Prmt9 cKO mice. Mechanistically, we discover a methylation-sensitive protein-RNA interaction between the arginine 508 (R508) of the splicing factor 3B subunit 2 (SF3B2), the site that is exclusively methylated by PRMT9, and the pre-mRNA anchoring site, a cis-regulatory element that is critical for RNA splicing. Additionally, using human and mouse cell lines, as well as an SF3B2 arginine methylation-deficient mouse model, we provide strong evidence that SF3B2 is the primary methylation substrate of PRMT9, thus highlighting the conserved function of the PRMT9/SF3B2 axis in regulating pre-mRNA splicing.
Keyphrases
  • mouse model
  • intellectual disability
  • genome wide
  • dna methylation
  • autism spectrum disorder
  • type diabetes
  • endothelial cells
  • gene expression
  • metabolic syndrome
  • small molecule
  • protein protein
  • wild type
  • brain injury